NCT02929420

A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule

A Multicenter, Randomized, Open, Parallel Controlled Clinical Study on the Efficacy and Safety of the Treatment of Cyclomastopathy With Xiaoru Sanjie Capsule

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 600 (estimated)
• Sponsor: First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
• Sex: Female
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of Xiaoru Sanjie capsule in the treatment of cyclomastopathy.

Detailed description

This is a multicenter, randomized, open and parallel controlled clinical study.

Conditions

• Fibrocystic Disease of Breast

Interventions

Type	Name	Description
DRUG	Xiaoru Sanjie capsules	Oral medication for a total of 90 days. According to the instructions, P.O., three times a day, each time three tablets, take a month as a treatment course, continuous use of 3 courses.
DRUG	Xiao Yao pills	Oral medication for a total of 90 days. According to the instructions, P.O., three times a day, each time three tablets, take a month as a treatment course, continuous use of 3 courses.

Timeline

• Start date: 2016-10-01
• Primary completion: 2017-12-01
• Completion: 2017-12-01
• First posted: 2016-10-11
• Last updated: 2016-10-11

Locations

1 site across 1 country: China